A customer used an automated teller machine (ATM) on Friday, April 14, 2023 at a Truist Bank branch in Dallas, Texas, USA.
Shelby Tauber |: Bloomberg |: Getty Images:
The healthcare industry has experienced rapid change over the past decade with the rise of digital services, creating a number of opportunities for investment.
TipRanks recognized the top 10 Wall Street analysts in the industry to identify the best investment opportunities. These analysts outperformed their peers with their stock picks and generated remarkable returns through their recommendations.
TipRanks used its Expert Center tool to identify those with high success rates. We’ve also analyzed every stock recommendation issued by healthcare analysts over the past decade.
The rating indicates analysts’ ability to generate returns from their offerings. TipRanks algorithms calculated the statistical significance of each rating, the average return, and the analysts’ overall success rate. In addition, each rating was measured over a period of one year.
Top 10 Healthcare Analysts
The image shows Wall Street’s most successful healthcare analysts, in descending order.
1. Thomas Smith – SVB Securities
Thomas Smith tops the list. Smith’s overall success rate is 51%. His best rating was Viking Therapeutics (NASDAQ: VKTX:), a clinical-stage biopharma company focused on the treatment of metabolic and endocrine disorders. His buy call on VKTX stock from April 27, 2022 to April 27, 2023 generated a stellar return of 791.30%.
2. Brandon Couillard – Jeffery
Brandon Couillard is second on this list and has a success rate of 68%. Couillard’s top tip is Exact sciences (GET IN. EXAS:), a provider of cancer screening and diagnostic tests. From May 4, 2016 to May 4, 2017, the analyst generated a 450% return on his buy recommendation for Exact Sciences stock.
3. David Windley – Jeffery
Jefferies analyst David Windley takes the top spot. 3 in the list. Windley’s success rate is 68%. His top recommendation was Medidata Solutions, a company with technology-based clinical expertise. Dassault Systemes later acquired Medidata. The analyst generated a 175.70% reversal with a buy recommendation on the August MDSO. 01, 2012 to Aug. 01, 2013.
4. John Eade – Argus Research
John Eade ranks fourth on the list. A five-star analyst has an overall success rate of 69%. Eade’s best offer was Modern (NASDAQ: mRNA:), a pharmaceutical and biotechnology company. His call on MRNA stock generated a return of 265.90% from June 30, 2020 to June 30, 2021.
5 Michael Wiederhorn – Oppenheimer
Fifth-place analyst Michael Wiederhorn has a 66% success rate. It’s her best advice Community health systems (NYSE: CYH:), a company engaged in the management and operation of hospitals. The featured analyst had a 298.2% gain on this stock from May 1, 2020 to May 1, 2021.
6. Charles Duncan – Cantor Fitzgerald
Charles Duncan occupies the sixth position. Analyst success rate is 52%. It was his main advice Nova wax (NASDAQ: NVAX:), a biotechnology company that develops vaccines. With his call on NVAX stock, Duncan generated a solid 800% return from March 17, 2020 to March 17, 2021.
7. Jaron Werber – TD Cowen
TD Cowen analyst Jaron Werber is seventh on this list with a 65% success rate. Werber’s best call was buying the stock Ultragenyx Pharmaceutical (NASDAQ: Rarity), a biopharmaceutical company focused on developing innovative medicines for rare and ultra-rare diseases. The offering generated a return of 267.50% since December. From 18 to Dec. 2019 18, 2020
8. From Geulah Livsh – Chardan capital
Charda Capital Geulah Livshitz is in eighth place. Livshits overall success rate is 42%. It is the analyst’s main advice Cabaletta biography (GET IN. KABA), a clinical-stage biotechnology company focused on developing treatments for autoimmune diseases. Based on his buy call on CABA, the analyst has gained 800% since October. 11, 2022 to now.
9. Richard Newiter – Truist Financial
Richard Newiter ranks ninth on the list. A five-star analyst has a 62% success rate. His main suggestion was Organogenesis (NASDAQ: ORGO), a regenerative medicine company that provides advanced wound care and surgical biologics products. The buy offer generated a return of 397.9% from May 12, 2020 to May 12, 2021.
10. Boris Picker – TD Cowen
Boris Picker ranks 10th on the list with 47% success. Peaker’s best call was buying shares in Trillium Therapeutics, a company developing a clinical-stage cancer therapy. Pfizer: ((NYSE:PFE) later acquired Trillium. The offer generated an 800% return since January. January 7, 2020 January 7, 2021
bottom line
Investors can follow the recommendations of leading analysts to make a well-informed investment decision. You can also look at all the analysts who made the top 100 list. We’ll be back soon with the best analysts of the last 10 years in the Consumer Goods industry.